Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Early Oseltamivir Treatment of Influenza in Children 1-3 Years of Age (ETOPOM)

This study has been completed.
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by:
Hospital District of Southwestern Finland
ClinicalTrials.gov Identifier:
NCT00593502
First received: January 4, 2008
Last updated: June 18, 2009
Last verified: June 2009